Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tryal is a private healthcare technology company focused on AI-powered eClinical software for clinical research teams at CROs, biopharma companies, and sponsors. The company develops workflow and document automation tools intended to accelerate clinical trial startup and related study operations, with capabilities spanning AI-assisted document generation, traceability, compliance support, impact analysis, and knowledge-base-driven content creation. Its flagship platform, Tryal Accelerator, is positioned to improve the speed, quality, and consistency of study documents by using protocol materials and other study-specific inputs rather than relying on isolated manual workflows. Historically, the company has also described broader eClinical offerings such as eCOA, eConsent, eSource/EDC, Televisit, home healthcare administration, and video anonymization services. Tryal is not a drug developer; it operates as an enabling technology vendor for the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tryal.